POWER INTEGRATIONS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that POWER INTEGRATIONS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $443.50M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $418.97M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $444.54M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $651.14M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $703.28M | Feb 12, 2024 |
| FY2020 | Dec 31, 2020 | $150.69M | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | $121.13M | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | $106.83M | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | $109.66M | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $114.46M | Feb 5, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $108.25M | Feb 14, 2018 |
| FY2017 | Sep 30, 2017 | $111.26M | Feb 14, 2018 |
| FY2017 | Jun 30, 2017 | $107.56M | Feb 14, 2018 |
| FY2017 | Mar 31, 2017 | $104.69M | Feb 14, 2018 |
| FY2017 | Dec 31, 2016 | $102.44M | Feb 14, 2018 |
| FY2017 | Sep 30, 2016 | $101.63M | Feb 14, 2018 |
| FY2017 | Jun 30, 2016 | $97.57M | Feb 14, 2018 |
| FY2017 | Mar 31, 2016 | $88.04M | Feb 14, 2018 |
| FY2016 | Dec 31, 2015 | $87.29M | Feb 8, 2017 |
| FY2016 | Sep 30, 2015 | $88.88M | Feb 8, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $241.65M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $224.75M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $228.96M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $366.91M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $360.64M | Feb 12, 2024 |
| FY2020 | Dec 31, 2020 | $74.01M | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | $59.57M | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | $53.54M | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | $56.48M | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $58.23M | Feb 5, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.09M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $32.23M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $55.74M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $170.85M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $164.41M | Feb 12, 2024 |
| FY2020 | Dec 31, 2020 | $27.28M | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | $14.82M | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | $13.19M | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | $15.89M | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $158.29M | Feb 5, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.19M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $17.93M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $35.06M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $180.41M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $175.06M | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | $70.49M | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $217.02M | Feb 7, 2022 |
| FY2020 | Dec 31, 2018 | $55.65M | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $57.64M | Feb 7, 2020 |
| FY2018 | Dec 31, 2016 | $48.87M | Feb 13, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $101.12M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $100.79M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $96.07M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $93.89M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $84.93M | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | $81.71M | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $73.47M | Feb 7, 2022 |
| FY2020 | Dec 31, 2018 | $70.58M | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $68.50M | Feb 7, 2020 |
| FY2018 | Dec 31, 2016 | $62.31M | Feb 13, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111.52M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $81.18M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $65.76M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $215.34M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $230.87M | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | $125.64M | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $224.50M | Feb 7, 2022 |
| FY2020 | Dec 31, 2018 | $83.96M | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $82.04M | Feb 7, 2020 |
| FY2018 | Dec 31, 2016 | $97.90M | Feb 13, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.40M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $17.29M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $20.88M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $39.21M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $47.27M | Feb 12, 2024 |
| FY2022 | Dec 31, 2020 | $70.60M | Feb 7, 2023 |
| FY2021 | Dec 31, 2019 | $24.11M | Feb 7, 2022 |
| FY2020 | Dec 31, 2018 | $24.68M | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $32.50M | Feb 7, 2020 |
| FY2018 | Dec 31, 2016 | $12.20M | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $772.21M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $828.83M | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $819.87M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $840.10M | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $1.01B | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | $903.34M | Feb 7, 2022 |
| FY2020 | Dec 31, 2019 | $803.90M | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $588.70M | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $621.07M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $554.41M | Feb 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.36M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $79.05M | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $67.63M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $84.88M | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $102.46M | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | $92.93M | Feb 7, 2022 |
| FY2020 | Dec 31, 2019 | $79.35M | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $61.63M | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $73.39M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $51.33M | Feb 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $672.85M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $749.77M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $752.24M | Feb 6, 2026 |
| FY2025 | Dec 31, 2022 | $755.22M | Feb 6, 2026 |
| FY2024 | Dec 31, 2021 | $912.03M | Feb 7, 2025 |
| FY2023 | Dec 31, 2020 | $810.41M | Feb 12, 2024 |
| FY2022 | Dec 31, 2019 | $724.55M | Feb 7, 2023 |
| FY2021 | Dec 31, 2018 | $527.07M | Feb 7, 2022 |
| FY2020 | Dec 31, 2017 | $547.68M | Feb 5, 2021 |
| FY2019 | Dec 31, 2016 | $503.08M | Feb 7, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.27M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $95.27M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $91.85M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $91.85M | Feb 7, 2025 |
| FY2022 | Dec 31, 2021 | $91.85M | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | $91.85M | Feb 7, 2022 |
| FY2020 | Dec 31, 2019 | $91.85M | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $91.85M | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $91.85M | Feb 13, 2019 |
| FY2018 | Dec 31, 2016 | $91.85M | Feb 13, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $673.93M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $734.04M | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $753.68M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $762.54M | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $753.44M | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | $621.63M | Feb 7, 2022 |
| FY2020 | Dec 31, 2019 | $575.53M | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $402.57M | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $351.41M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $332.89M | Feb 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.76M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $50.97M | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $63.93M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $105.37M | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | $158.12M | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | $258.87M | Feb 7, 2022 |
| FY2020 | Dec 31, 2019 | $178.69M | Feb 5, 2021 |
| FY2020 | Dec 31, 2018 | $134.14M | Feb 5, 2021 |
| FY2020 | Dec 31, 2017 | $93.66M | Feb 5, 2021 |
| FY2019 | Dec 31, 2016 | $62.13M | Feb 7, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 12, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 5, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 12, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 5, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 55.34M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 56.84M | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | 56.74M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | 56.96M | Feb 12, 2024 |
| FY2022 | Dec 31, 2021 | 59.91M | Feb 7, 2023 |
| FY2021 | Dec 31, 2020 | 59.91M | Feb 7, 2022 |
| FY2020 | Dec 31, 2019 | 58.86M | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | 28.89M | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | 29.78M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | 29.25M | Feb 14, 2018 |